Fundraising Fox
🦊/Companies
Sign in

Viridian Therapeutics

Waltham, US · Founded 2020 · Delaware corporation · 3 known investors

Find your way into Viridian Therapeutics

58 people in our graph share verified history with the Viridian Therapeutics team — schools, employers, funds. One of them is your warm intro.

Brandon Sheltonunlockedknows Jonathan Violin · together at Duke University - The Fuqua School of Business (overlapped)
×7knows the team · via Duke University - The Fuqua School of Business
knows the team · via Korsana
×3knows the team · via UC San Diego School of Medicine

Viridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.

BiotechDigital HealthMedical Devices

Founders & leadership

Viridian Therapeutics was founded in 2020 by Jonathan Violin.

JVJonathan Violin
Jonathan ViolininFounderJonathan Violin is an executive officer and director at Viridian Therapeutics, which develops treatments for thyroid eye disease. He has held CEO and board positions at biotech companies and has experience in drug discovery, capital raising, and scientific leadership.

Board

PH
Peter HarwinBoard director
TK
Tomas KiselakBoard director

Investors · 3

Broadview VenturesBoston
Longitude CapitalMenlo Park · $10M – $30M
MRL Ventures FundCambridge · $25M

Reported raises · per SEC filings

Form D private placements

$29M disclosed across 2 rounds · 2020

▶$27MraisedSep 2020 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan ViolinExecutive Officer, Director
  • Tomas KiselakDirector
  • Peter HarwinDirector
Offering amount
$27M
Amount sold
$27M
First sale
Sep 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedMay 2020 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan ViolinExecutive Officer, Director
  • Peter HarwinDirector
  • Tomas KiselakDirector
Offering amount
$5M
Amount sold
$2M
First sale
Apr 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Bioworld59 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies competing with Viridian Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Jupiter Topco LLC Buys Shares of 27,472 Viridian Therapeutics, Inc. $VRDN - American Market Newsamericanbankingnews.com · Sep 2026Viridian at Wells Fargo conference: launch gains and pipeline build By Investing.cominvesting.com · Sep 2026How Strong REVEAL-2 Data and Fresh Capital Raises Could Shape Viridian Therapeutics (VRDN) Investors - Simply Wall St Newssimplywall.st · May 2026Viridian Therapeutics Raises $359 Million in Offerings - TipRanks.comtipranks.com · May 2026Viridian Therapeutics Raises $350 Million Through Upsized...marketchameleon.com · May 2026Viridian Therapeutics launches $250 million capital raise By Investing.cominvesting.com · May 2026

Frequently asked questions

What does Viridian Therapeutics do?
Viridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit. The company focuses on clinical development and patient support programs in the biotech sector.
Who founded Viridian Therapeutics?
Viridian Therapeutics was founded by Jonathan Violin in 2020.
Who are Viridian Therapeutics's investors?
Viridian Therapeutics's investors include Broadview Ventures, Longitude Capital, MRL Ventures Fund.
How much funding has Viridian Therapeutics raised?
Viridian Therapeutics has disclosed $29M raised across 2 rounds.
Where is Viridian Therapeutics headquartered?
Viridian Therapeutics is headquartered in Waltham, US.